Survodutide

Survodutide (development name BI 456906) is a dual agonist at GLP-1 and glucagon receptors. That places it right between the others: semaglutide hits only GLP-1, retatrutide three receptors, and survodutide two, namely GLP-1 plus glucagon, but no GIP. The ratio is GLP-1-leaning (about 8 to 1), with the glucagon share in a supporting role.

It is injected once a week. Survodutide is not approved yet but in the middle of clinical research (the phase 3 SYNCHRONIZE programme). It ships as a freeze-dried powder you dissolve in bacteriostatic water before the first use.

The GLP-1 part does what you know from semaglutide and co.: it boosts the insulin response, slows gastric emptying and dampens appetite, the food noise gets quieter. The glucagon part comes in support and mainly raises energy expenditure and fat breakdown, especially in the liver.

Studies suggest this combination moves more on weight and especially on liver fat than GLP-1 alone. But because the focus clearly sits on GLP-1, the glucagon effect is milder than in the triple agonist retatrutide.

Before you start, have everything ready. The list is short:

• The Survodutide vial with the freeze-dried powder
• Bacteriostatic water to dissolve it
• U-100 insulin syringes for the injection (they also work for drawing the water, you just draw more often; a larger syringe is faster but not a must)
• Alcohol swabs for the vial cap and the skin
• A sealable sharps container for used needles

With everything clean and in one place, the rest is straightforward.

The powder is dissolved in bacteriostatic water. How much water you add sets the concentration, and with it how many units you later draw on the insulin syringe for your dose.

Use the calculator above for exactly this: pick the water volume, and you instantly see the concentration and the units per dose. Roughly: less water means higher concentration and fewer units.

When dissolving, just add the bac water and let the powder dissolve. It does not matter if the water hits the powder directly, and swirling or shaking are both fine.

The injection is subcutaneous, into the fat layer under the skin. Common spots are the abdomen (keep about two finger-widths clear of the navel), the front of the thigh, or the back of the upper arm.

The short version:

• Clean the spot with an alcohol swab and let it dry
• Pinch up a small fold of skin
• Insert the needle at a 45 to 90 degree angle
• Inject slowly, wait a moment, then withdraw
• Put the needle straight into the sharps container

Rotate the site each time so the tissue does not get irritated. Never the same spot twice in a row.

Survodutide is well documented in phase 2 studies but still pre-approval. In the obesity study (le Roux, 2024), weight dropped dose-dependently over 46 weeks, by nearly 15 percent on average at the highest dose, and up to about 19 percent among those who completed. In a liver study (Sanyal, 2024), MASH (a form of fatty-liver inflammation) improved in a large share of participants, far more often than on placebo. A smaller diabetes study also showed a clear drop in long-term blood sugar (HbA1c).

The individual studies with links are in the source block below.

Like the whole class, gastrointestinal effects come first: nausea, fullness, sometimes diarrhoea or constipation. In the studies this was clearly dose-dependent and well manageable through the stepwise titration. The glucagon share is exactly why you ease in slowly and do not go up too fast.

Survodutide takes the hunger away, the rest is on you. A few things get more out of the research phase and keep you healthy:

• Enough protein. If you eat little, make the little you eat protein-rich, or you lose muscle along with fat.
• Drink enough. With low appetite you often drink less without noticing, and the risk of dehydration goes up.
• Resistance training. Keeps muscle mass while the weight comes off.
• Eat slowly. With delayed gastric emptying you fill up faster, big portions sit heavy.

Alcohol and very fatty meals make the nausea noticeably worse, especially early on.

The undissolved powder is robust, normal room temperature (around 20 to 25 degrees) is fine, ideally kept in the dark. Once dissolved, the solution goes into the fridge (2 to 8 degrees) and stays stable there for at least 8 to 10 weeks with barely any loss of potency, in practice considerably longer. The bacteriostatic water brings a preservative that keeps the dissolved form stable for longer.